Nonproliferative breast changes (fibrocystic)
- Lesion
Lumpy breasts with cysts are so common they are almost normal; these changes do not raise the risk of breast cancer.
What it is
Nonproliferative breast changes, also called fibrocystic changes, are the most common breast lesions, appearing during the reproductive years under hormonal influence. They consist of cysts, often lined by apocrine metaplasia, fibrosis of the stroma, and adenosis, an increase in the number of acini. They cause lumps, tenderness and mammographic calcifications, but do not increase the risk of breast cancer.
Structure
- Gross: rubbery, lumpy tissue with cysts of varying size, sometimes containing turbid or brown fluid.
- Cysts lined by flattened or apocrine epithelium over myoepithelium; calcifications may lie in the secretions.
- Stroma: increased dense collagen with scattered chronic inflammatory cells.
Step by step
- Cyclic estrogen and progesterone stimulate the terminal duct lobular units.
- Lobules dilate into cysts; their lining often changes to apocrine cells.
- Secretions within cysts may calcify, producing mammographic calcifications.
- Cysts rupture, inflammation follows, and fibrosis makes the breast firmer and lumpier.
Clinical notes
- Lumpiness and premenstrual tenderness, most noticeable in the twenties to the menopause.
- A dominant cyst can be aspirated; clear fluid with complete collapse is reassuring.
- Because cysts and calcifications can resemble cancer on imaging, some need biopsy to be sure.
Test yourself
Think of the answer, then tap the question to see it.
What are the three components of nonproliferative breast changes?
Cysts (often with apocrine metaplasia), fibrosis and adenosis.
Do nonproliferative changes raise breast cancer risk?
No; the risk is the same as in the general population.
What is apocrine metaplasia?
Change of the cyst lining to cells with abundant pink granular cytoplasm and apical snouts, resembling apocrine sweat glands.
Elsewhere in DurgiPedia
Connections
Educational content on the mechanisms of disease; not a diagnostic or treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Fibrocystic Breast Disease (StatPearls (NCBI Bookshelf), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.